Hemlibra – Talk Bio

Roche in Talks With US on Drug Pricing; Sets Out Pipeline and Dealmaking Ambitions

4 days ago talkbio0Tagged Benefit, dealmaking, direct-to-consumer sales, drug price, gene therapy, Government, Hemlibra, Investments, manager, Manufacturing, Ocrevus, Pharmaceutical Services, pipeline, R&D, Roche (company), U.S., Vabysmo

Roche; drug pricing; US government; pharmacy benefit managers; direct-to-consumer sales; pipeline; dealmaking; US investment; manufacturing; gene therapy; R&D; Ocrevus; Hemlibra; Vabysmo

Roche Discontinues Second Hemophilia A Gene Therapy Candidate Under Spark Amid Shift in Hematologic Portfolio

10 months ago talkbio0Tagged gene therapy, Hemlibra, Hemophilia A, Roche (company)

Roche, Spark Therapeutics, Hemophilia A, Gene Therapy, RG6358, SPK-8016, Hemlibra, SPK-8011

Novel Monthly Hemophilia A Treatment by Novos Poses Challenge to Roche’s Hemlibra

1 year ago talkbio0Tagged Hemlibra, Hemophilia A, Monthly (qualifier value), Novos, Performance, Roche (company)

Hemophilia A, Novos, Roche, Hemlibra, monthly treatment, performance, challenge.